Design and Application in Delivery System of Intranasal Antidepressants
One of the major reasons why depressed patients fail their treatment course is the existence of the blood-brain barrier (BBB), which prevents drugs from being delivered to the central nervous system (CNS). In recent years, nasal drug delivery has achieved better systemic bioavailability and activity...
Main Authors: | Jingying Xu, Jiangang Tao, Jidong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2020.626882/full |
Similar Items
-
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
by: Zhiyu Jin, et al.
Published: (2022-09-01) -
Thermosensitive hydrogel designed for improving the antidepressant activities of genipin via intranasal delivery
by: Xue-Jie Qi, et al.
Published: (2021-08-01) -
Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug
by: Mohammed Ghazwani, et al.
Published: (2023-06-01) -
Alginate nanogels-based thermosensitive hydrogel to improve antidepressant-like effects of albiflorin via intranasal delivery
by: Dong Xu, et al.
Published: (2021-01-01) -
Clinical and pharmacokinetics overview of intranasal administration of fentanyl
by: Samaneh Nakhaee, et al.
Published: (2023-12-01)